Mesencephalic astrocyte-derived neurotrophic factor inhibits cervical cancer progression via regulating macrophage

Miaomiao Huang1,2,3,4,5,6, Jingjing Hu1,2,3,4,5,6, Yueran Chen1

  • 1Department of Obstetrics and Gynecology, The First Affiliated Hospital of Anhui Medical University, No. 218 Jixi Road, Hefei, 230022, Anhui, China.

PubMed
Abstract

Insights

Mesencephalic astrocyte-derived neurotrophic factor (MANF) inhibits cervical cancer progression. MANF-silenced macrophages promote tumor growth, suggesting MANF as a therapeutic target.

Area of Science:

  • Oncology
  • Immunology

Background:

  • Cervical cancer progression factors remain unclear.
  • Mesencephalic astrocyte-derived neurotrophic factor (MANF) is known for anti-inflammatory properties and macrophage regulation.

Purpose of the Study:

  • To explore the effect and mechanism of MANF in cervical cancer.
  • To investigate MANF's role in regulating macrophage polarization in cervical cancer.

Main Methods:

  • Immunohistochemistry and western blot for MANF expression.
  • qRT-PCR for MANF mRNA levels.
  • Dual-labeled immunofluorescence to locate MANF in macrophages.
  • In vitro assays with MANF-silenced macrophages and cervical cancer cells (HeLa, SiHa).
  • In vivo tumor formation assay in nude mice.

Main Results:

  • MANF was highly expressed in peritumoral tissues and primarily located in macrophages.
  • MANF-silenced macrophages promoted cervical cancer cell survival, migration, invasion, and epithelial-mesenchymal transition (EMT) via NF-κB signaling.
  • MANF-silenced macrophages enhanced cervical tumor formation in vivo.

Conclusions:

  • MANF exhibits an inhibitory role in cervical cancer progression.
  • MANF represents a potential therapeutic target for cervical cancer treatment.